MCM
BIOL

Murphy Capital Management’s Biolase, Inc. BIOL Stock Holding History

Murphy Capital Management’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-4
Closed -$125K – 352
2014
Q4 		$125K Hold
4
– – 0.02% 321
2014
Q3 		$118K Hold
4
– – 0.02% 327
2014
Q2 		$105K Hold
4
– – 0.02% 331
2014
Q1 		$130K Buy
4
+1
+33% +$34.9K 0.02% 318
2013
Q4 		$113K Buy
+3
New +$71.1K 0.02% 311

Other funds holding BIOL

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PCMI
Princeton Capital Management Inc Princeton, New Jersey $198M AUM 28.98% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Murphy Capital Management's BIOL Position: Q1 2015 in Review

Murphy Capital Management sold out of Biolase, Inc. (BIOL) in Q1 2015, closing a stake of 4 shares — an estimated $125K sold.

Murphy Capital Management first reported a position in BIOL in Q4 2013 and held it in 5 quarters. The position peaked at $130K in Q1 2014. 36 funds tracked by Wall St. Rank hold BIOL as of Q1 2015.

  • Murphy Capital Management reported no remaining Biolase, Inc. position as of Q1 2015 after selling out during the quarter.
  • Murphy Capital Management sold 4 Biolase, Inc. shares in Q1 2015, an estimated $125K.
  • Murphy Capital Management first reported a position in Biolase, Inc. in Q4 2013 and held it in 5 quarters.
  • Murphy Capital Management's Biolase, Inc. position peaked at $130K in Q1 2014.
  • 36 funds tracked by Wall St. Rank held Biolase, Inc. as of Q1 2015.

Based on Murphy Capital Management's 13F filing for Q1 2015, filed 14 Apr 2015.